Mitoxantron-BP 2 mg/ml concentrat pentru soluţie perfuzabilă Moldova - rumāņu - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

mitoxantron-bp 2 mg/ml concentrat pentru soluţie perfuzabilă

sc balkan pharmaceuticals srl - mitoxantronum - concentrat pentru soluţie perfuzabilă - 2 mg/ml

Zeposia Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

zeposia

bristol-myers squibb pharma eeig - ozanimod clorhidrat de - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresoare - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.

TEMSIROLIMUS ACCORD 30 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

temsirolimus accord 30 mg

accord healthcare polska sp. z. o.o. - polonia - temsirolimusum - conc. si solv. pt. sol. perf. - 30mg - inhibitori de protein-kinaza

Dimethyl fumarate Mylan Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

dimethyl fumarate mylan

mylan ireland limited - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Polpharma Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

dimethyl fumarate polpharma

zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

Dimethyl fumarate Neuraxpharm Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

dimethyl fumarate neuraxpharm

laboratorios lesvi s.l. - fumarat de dimetil - scleroză multiplă, scleroză multiplă recurent-remisivă - imunosupresoare - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.

DIMTRUZIC 120 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dimtruzic 120 mg

lek pharmaceuticals d.d. - slovenia - dimetil fumarat - caps. gastrorez. - 120mg - imunosupresoare alte imunosupresoare

DIMTRUZIC 240 mg Rumānija - rumāņu - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

dimtruzic 240 mg

lek pharmaceuticals d.d. - slovenia - dimetil fumarat - caps. gastrorez. - 240mg - imunosupresoare alte imunosupresoare

Spevigo Eiropas Savienība - rumāņu - EMA (European Medicines Agency)

spevigo

boehringer ingelheim international gmbh - spesolimab - psoriazis - imunosupresoare - spevigo is indicated for the treatment of flares in adult patients with generalised pustular psoriasis (gpp) as monotherapy.